Trends of Antifungal Use Based on Sales Data in Japan from 2006 to 2015-Reference-Cited by-同舟云学术

Trends of Antifungal Use Based on Sales Data in Japan from 2006 to 2015

Published:2020-08-01 Issue:8 Volume:43 Page:1248-1252
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Kawabe Ayako¹,Muraki Yuichi¹,Inose Ryo¹,Kusama Yoshiki²,Goto Ryota¹,Ebisui Ai¹,Ishii Saki¹,Ishikane Masahiro²,Ohge Hiroki³,Ohmagari Norio²

Affiliation:

1. Department of Clinical PharmacoEpidemiology, Kyoto Pharmaceutical University

2. AMR Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine

3. Department of Infectious Diseases, Hiroshima University Hospital

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/43/8/43_b20-00302/_pdf

Reference18 articles.

1. 1) Cornely OA, Gachot B, Akan H, Bassetti M, Uzun O, Kibbler C, Marchetti O, de Burghgraeve P, Ramadan S, Pylkkanen L, Ameye L, Paesmans M, Donnelly JP. Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clin. Infect. Dis., 61, 324–331 (2015).

2. 2) Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin. Infect. Dis., 32, 358–366 (2001).

3. 3) Permanyer I, Scholl N. Global trends in lifespan inequality: 1950–2015. PLOS ONE, 14, e0215742 (2019).

4. 4) Statistics Bureau of Japan. “Elderly population.”: ‹http://www.stat.go.jp/data/topics/topi1031.html›, accessed 24 January, 2020.

5. 5) Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 68, 394–424 (2018).

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Necessity for a System Implementing Therapeutic Drug Monitoring in Outpatient Settings Based on the Actual Use of Voriconazole Using the National Database of Health Insurance Claims and Specific Health Checkups of Japan: A Descriptive Epidemiological Study;Biological and Pharmaceutical Bulletin;2023-10-01

2. Distribution, trends, and antifungal susceptibility ofCandidaspecies causing candidemia in Japan, 2010–2019: A retrospective observational study based on national surveillance data;Medical Mycology;2022-09

3. A Strategy for Hospital Pharmacists to Control Antimicrobial Resistance (AMR) in Japan;Antibiotics;2021-10-21

4. Species Distribution of Candidemia and Their Susceptibility in a Single Japanese University Hospital: Prior Micafungin Use Affects the Appearance of Candida parapsilosis and Elevation of Micafungin MICs in Non-parapsilosis Candida Species;Journal of Fungi;2021-07-23

5. An alternative index for evaluating AMU and anti-methicillin-resistant Staphylococcus aureus agent use: A study based on the National Database of Health Insurance Claims and Specific Health Checkups data of Japan;Journal of Infection and Chemotherapy;2021-07